According to Hemab Therapeutics Holdings's latest financial reports the company's current EPS (TTM) is -ยฃ1.73. In 2025 the company made an earnings per share (EPS) of -ยฃ1.73 a decrease over its 2024 EPS that were of -ยฃ1.31.